Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 105
Filtrar
1.
Arq. Ciênc. Vet. Zool. UNIPAR (Online) ; 25(2): e6378, jul-dez. 2022.
Artículo en Portugués | LILACS, VETINDEX | ID: biblio-1399609

RESUMEN

Os resíduos provenientes da aquicultura são derivados da ração e da excreção dos peixes e podem estar sedimentados, suspensos ou dissolvidos, ocasionando elevados valores de DBO, DQO, nitrogênio e fósforo. A produção de camarões no Brasil tem gerado elevadas quantidades de resíduos sólidos, tendo em vista que os exoesqueletos dos camarões correspondem a cerca de 40% do seu peso total, resultando num forte impacto ambiental. Diversas pesquisas envolvendo a quitina estão sendo desenvolvidas na área de tratamento de água, devido principalmente a sua capacidade de formar filme, sendo utilizada em sistemas filtrantes. Este polissacarídeo também pode ser utilizado como agente floculante no tratamento de efluentes, como adsorvente na clarificação de óleos, e principalmente na produção de quitosana. Atualmente a quitosana possui aplicações multidimensionais, desde áreas como a nutrição humana, biotecnologia, ciência dos materiais, indústria farmacêutica, agricultura, terapia genética e proteção ambiental. A quitosana é muito eficiente na remoção de poluentes em diferentes concentrações. Apresenta alta capacidade e grande velocidade de adsorção, boa eficiência e seletividade tanto em soluções que possuem altas ou baixas concentrações. O uso da biotecnologia, através do processo de adsorção utilizando adsorventes naturais e baratos, como a quitina e quitosana, minimiza os impactos ambientais da aquicultura tanto em relação aos provocados pelo lançamento de efluentes no meio ambiente quanto aos causados pelo descarte inadequado dos resíduos do processamento de camarões.(AU)


Aquaculture residues are derived from fish feed and excretion and may be sedimented, suspended or dissolved, resulting in high BOD, COD, nitrogen and phosphorus values. Shrimp production in Brazil has generated high amounts of solid waste, since shrimp exoskeletons account for about 40% of their total weight, resulting in a strong environmental impact. Several researches involving chitin are being developed in the area of water treatment, mainly due to its ability to form film, being used in filter systems. This polysaccharide can also be used as a flocculating agent in the treatment of effluents, as an adsorbent in the clarification of oils, and especially in the production of chitosan. Currently, chitosan has multidimensional applications, from areas such as human nutrition, biotechnology, materials science, pharmaceutical industry, agriculture, gene therapy and environmental protection. Chitosan is very efficient in the removal of pollutants at different concentrations. It presents high capacity and high adsorption velocity, good efficiency and selectivity both in solutions that have high or low concentrations. The use of biotechnology, through the adsorption process using natural and cheap adsorbents such as chitin and chitosan, minimizes the environmental impacts of aquaculture both in relation to those caused by the release of effluents into the environment and those caused by the inappropriate disposal of processing residues of shrimps.(AU)


Los residuos procedentes de la acuicultura se derivan de la ración y de la excreción de los peces y pueden estar sedimentados, suspendidos o disueltos, ocasionando elevados valores de DBO, DQO, nitrógeno y fósforo. La producción de camarones en Brasil ha generado grandes cantidades de residuos sólidos, teniendo en cuenta que los exoesqueletos de los camarones corresponden a cerca del 40% de su peso total, resultando en un fuerte impacto ambiental. Varias investigaciones involucrando la quitina se están desarrollando en el área de tratamiento de agua, debido principalmente a su capacidad de formar película, siendo utilizada en sistemas filtrantes. Este polisacárido también puede ser utilizado como agente floculante en el tratamiento de efluentes, como adsorbente en la clarificación de aceites, y principalmente en la producción de quitosana. Actualmente la quitosana posee aplicaciones multidimensionales, desde áreas como la nutrición humana, biotecnología, ciencia de los materiales, industria farmacéutica, agricultura, terapia genética y protección ambiental. La quitosana es muy eficiente en la eliminación de contaminantes en diferentes concentraciones. Presenta alta capacidad y gran velocidad de adsorción, buena eficiencia y selectividad tanto en soluciones que poseen altas o bajas concentraciones. El uso de la biotecnología, a través del proceso de adsorción utilizando adsorbentes naturales y baratos, como la quitina y quitosana, minimiza los impactos ambientales de la acuicultura tanto en relación a los provocados por el lanzamiento de efluentes en el medio ambiente en cuanto a los causados por el descarte inadecuado de los residuos del procesamiento de camarones.(AU)


Asunto(s)
Quitina/administración & dosificación , Adsorción/efectos de los fármacos , Quitosano/administración & dosificación , Aguas Residuales/química , Biopolímeros/análisis , Acuicultura , Eutrofización/fisiología , Amoníaco/química
2.
Poult Sci ; 98(7): 2781-2789, 2019 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-30778562

RESUMEN

This work aimed to investigate the effects of the palygorskite (PAL) composites on the growth performance and antioxidant status in broiler chickens. A total of 192 one-day-old Ross 308 broilers were randomly divided into 3 treatment groups. Broilers were fed basal diets supplemented with either 50 mg/kg chlortetracycline (CTC group), 1 g/kg ZnO/PAL (ZnO/PAL group), or 1 g/kg chitooligosaccharides/ZnO/PAL (COS/ZnO/PAL group), respectively. The results showed that PAL composites were found to exhibit similar effects on growth performance as CTC (P > 0.05). ZnO/PAL and COS/ZnO/PAL enhanced the activity of serum glutathione peroxidase (GSH-Px) compared with CTC both at 21 and 42 d (P < 0.05). Compared with the CTC group, COS/ZnO/PAL enhanced serum catalase (CAT) activity at 21 d (P < 0.05), and decreased serum malondialdehyde (MDA) content at 42 d (P < 0.05). Compared with the CTC group, ZnO/PAL decreased duodenal mucous MDA content at 21 d, while ZnO/PAL did not affect activities of superoxide dismutase (SOD) and GSH-Px in the duodenum (P > 0.05). The duodenal mucous activities of SOD and GSH-Px were the highest in the COS/ZnO/PAL group at 42 d (P < 0.05). At 21 d, broilers in the COS/ZnO/PAL group had the lowest MDA content and the highest total antioxidant capacity (T-AOC) in the jejunum (P < 0.05). Palygorskite composites decreased ileum mucous MDA content compared with CTC treated broilers at 21 d (P < 0.05). At 42 d, ileum mucous T-AOC was increased both in the ZnO/PAL and COS/ZnO/PAL groups compared with the CTC group (P < 0.05). The ileum mucous GSH-Px activities both in the ZnO/PAL and COS/ZnO/PAL groups were increased compared with the CTC group (P < 0.05). In conclusion, the broilers given the basal diet supplemented with the PAL composites exhibited similar growth performance to their counterparts in the AGP group. Additionally, the PAL composites improved the antioxidant status of broilers and the beneficial effects of COS/ZnO/PAL on the antioxidant status are more pronounced.


Asunto(s)
Alimentación Animal/análisis , Antioxidantes/metabolismo , Pollos/crecimiento & desarrollo , Compuestos de Magnesio/farmacología , Compuestos de Silicona/farmacología , Animales , Catalasa/sangre , Quitina/administración & dosificación , Quitina/análogos & derivados , Quitina/farmacología , Quitosano , Clortetraciclina/administración & dosificación , Clortetraciclina/farmacología , Dieta/veterinaria , Mucosa Gástrica/metabolismo , Glutatión Peroxidasa/sangre , Compuestos de Magnesio/administración & dosificación , Masculino , Malondialdehído/sangre , Oligosacáridos , Compuestos de Silicona/administración & dosificación , Superóxido Dismutasa/análisis , Óxido de Zinc/administración & dosificación , Óxido de Zinc/farmacología
3.
Infect Immun ; 86(11)2018 11.
Artículo en Inglés | MEDLINE | ID: mdl-30104216

RESUMEN

Developing an effective and safe recombinant vaccine requires microbe-specific antigens combined with an adjuvant/delivery system to strengthen protective immunity. In this study, we designed and expressed a multivalent recombinant Coccidioides polypeptide antigen (rCpa1) that consists of three previously identified antigens (i.e., Ag2/Pra, Cs-Ag, and Pmp1) and five pathogen-derived peptides with high affinity for human major histocompatibility complex class II (MHC-II) molecules. The purified rCpa1 was encapsulated into four types of yeast cell wall particles containing ß-glucan, mannan, and chitin in various proportions or was mixed with an oligonucleotide (ODN) containing two methylated dinucleotide CpG motifs. This multivalent antigen encapsulated into glucan-chitin particles (GCP-rCpa1) showed significantly greater reduction of fungal burden for human HLA-DR4 transgenic mice than the other adjuvant-rCpa1 formulations tested. Among the adjuvants tested, both GCPs and ß-glucan particles (GPs) were capable of stimulating a mixed Th1 and Th17 response. Mice vaccinated with GCP-rCpa1 showed higher levels of interleukin 17 (IL-17) production in T-cell recall assays and earlier lung infiltration by activated Th1 and Th17 cells than GP-rCpa1-vaccinated mice. Both C57BL/6 and HLA-DR4 transgenic mice that were vaccinated with the GCP-rCpa1 vaccine showed higher survival rates than mice that received GCPs alone. Concurrently, the GCP-rCpa1 vaccine stimulated greater infiltration of the injection sites by macrophages, which engulf and process the vaccine for antigen presentation, than the GP-rCpa1 vaccine. This is the first attempt to systematically characterize the presentation of a multivalent coccidioidomycosis vaccine encapsulated with selected adjuvants that enhance the protective cellular immune response to infection.


Asunto(s)
Adyuvantes Inmunológicos/administración & dosificación , Quitina/administración & dosificación , Coccidioides/inmunología , Coccidioidomicosis/prevención & control , Glucanos/administración & dosificación , Vacunas Antiprotozoos/inmunología , Células Th17/inmunología , Animales , Antígenos de Protozoos/genética , Antígenos de Protozoos/inmunología , Modelos Animales de Enfermedad , Sistemas de Liberación de Medicamentos , Antígeno HLA-DR4/genética , Antígeno HLA-DR4/metabolismo , Humanos , Ratones Endogámicos C57BL , Ratones Transgénicos , Nanopartículas/administración & dosificación , Oligodesoxirribonucleótidos/administración & dosificación , Unión Proteica , Vacunas Antiprotozoos/administración & dosificación , Vacunas Antiprotozoos/genética , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/inmunología , Análisis de Supervivencia , Células TH1/inmunología , Vacunas Sintéticas/administración & dosificación , Vacunas Sintéticas/genética , Vacunas Sintéticas/inmunología
4.
Mar Drugs ; 16(2)2018 Feb 19.
Artículo en Inglés | MEDLINE | ID: mdl-29463060

RESUMEN

Gut microbiota has been proved to be an indispensable link between nutrient excess and metabolic syndrome, and chitin oligosaccharide (NACOS) has displayed therapeutic effects on multiple diseases such as cancer and gastritis. In this study, we aim to confirm whether NACOS can ameliorate high-fat diet (HFD)-induced metabolic syndrome by rebuilding the structure of the gut microbiota community. Male C57BL/6J mice fed with HFD were treated with NACOS (1 mg/mL) in drinking water for five months. The results indicate that NACOS improved glucose metabolic disorder in HFD-fed mice and suppressed mRNA expression of the protein regulators related to lipogenesis, gluconeogenesis, adipocyte differentiation, and inflammation in adipose tissues. Additionally, NACOS inhibited the destruction of the gut barrier in HFD-treated mice. Furthermore, 16S ribosome RNA sequencing of fecal samples demonstrates that NACOS promoted the growth of beneficial intestinal bacteria remarkably and decreased the abundance of inflammogenic taxa. In summary, NACOS partly rebuilt the microbial community and improved the metabolic syndrome of HFD-fed mice. These data confirm the preventive effects of NACOS on nutrient excess-related metabolic diseases.


Asunto(s)
Quitina/administración & dosificación , Dieta Alta en Grasa/efectos adversos , Microbioma Gastrointestinal/efectos de los fármacos , Síndrome Metabólico/tratamiento farmacológico , Oligosacáridos/administración & dosificación , Tejido Adiposo/efectos de los fármacos , Tejido Adiposo/metabolismo , Animales , Diferenciación Celular/efectos de los fármacos , Tracto Gastrointestinal/microbiología , Gluconeogénesis/efectos de los fármacos , Glucosa/metabolismo , Inflamación/tratamiento farmacológico , Inflamación/metabolismo , Inflamación/microbiología , Lipogénesis/efectos de los fármacos , Masculino , Síndrome Metabólico/microbiología , Ratones , Ratones Endogámicos C57BL
5.
Int J Mol Sci ; 18(2)2017 Jan 27.
Artículo en Inglés | MEDLINE | ID: mdl-28134832

RESUMEN

This study investigated the prophylactic effects of orally administered surface-deacetylated chitin nanofibers (SDACNFs) and chitosan against 5-fluorouracil (5-FU)-induced intestinal mucositis, which is a common side effect of 5-FU chemotherapy. SDACNFs and chitosan abolished histological abnormalities associated with intestinal mucositis and suppressed hypoproliferation and apoptosis of intestinal crypt cells. These results indicate that SDACNF and chitosan are useful agents for preventing mucositis induced by anti-cancer drugs.


Asunto(s)
Quitina/administración & dosificación , Quitina/uso terapéutico , Quitosano/uso terapéutico , Fluorouracilo/efectos adversos , Mucositis/inducido químicamente , Mucositis/tratamiento farmacológico , Nanofibras/química , Acetilación , Administración Oral , Animales , Apoptosis/efectos de los fármacos , Caspasa 3/metabolismo , Quitina/farmacología , Quitosano/administración & dosificación , Quitosano/farmacología , Femenino , Inmunohistoquímica , Etiquetado Corte-Fin in Situ , Antígeno Ki-67/metabolismo , Ratones Endogámicos C57BL , Nanofibras/administración & dosificación , Nanofibras/ultraestructura , Peroxidasa/metabolismo
6.
Int J Pharm ; 511(2): 1080-7, 2016 Sep 25.
Artículo en Inglés | MEDLINE | ID: mdl-27521704

RESUMEN

A freeze-dried gel composed of surface-deacetylated chitin nanofibers (SDACNFs), reinforced with an anionic cyclodextrin, sulfobutyl ether ß-cyclodextrin (SBE-ß-CD) was evaluated for treating wounds in a rat model, and the results were compared with a SDACNFs gel without SBE-ß-CD. The incorporation of prednisolone (PD), a poorly water-soluble drug, in both types of gels and its release from the gels were also compared. In both cases, wound areas were decreased and their effect was higher than that of commercially available wound dressings. The rate of release of PD from the freeze-dried SDACNFs/SBE-ß-CD was much faster than that form SDACNFs alone without SBE-ß-CD, due to fact that the PD is more soluble in the amorphous SBE-ß-CD complex compared to the other preparations. The findings indicate that the freeze-dried SDACNFs/SBE-ß-CD gel would be beneficial as a new biomaterial for the treatment of wounds and for preparing homogeneous high-content gels that contain poorly water-soluble drugs.


Asunto(s)
Vendajes , Materiales Biocompatibles/química , Quitina/química , Nanofibras/química , Cicatrización de Heridas/efectos de los fármacos , beta-Ciclodextrinas/química , Animales , Materiales Biocompatibles/administración & dosificación , Quitina/administración & dosificación , Liberación de Fármacos , Femenino , Liofilización/métodos , Nanofibras/administración & dosificación , Ratas , Ratas Wistar , beta-Ciclodextrinas/administración & dosificación
7.
Inflammation ; 39(3): 1108-15, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27075589

RESUMEN

Small-sized chitin and chitosan microparticles (MPs) reduce allergic inflammation. We examined the capacity of these glycans to stimulate A549 human airway epithelial cells to determine the feasibility of using of these glycans as allergic therapeutic modality. A549 cells were treated with MPs and then expressions levels of chitinase domain-containing 1 (CHID1) and chitinase 3-like 1 (CHI3L1) genes were determined by quantitative real-time PCR. IL-6 production was measured by ELISA. Chitin MPs resulted in upregulation of CHI3L1 expression by 35.7-fold while mRNA expression did not change with chitosan MPs. Compared to the untreated group, production of IL-6 was significantly decreased in the chitosan MPs-treated group, but chitin MPs treatment cause elevation of IL-6 level. This study demonstrates that chitin potently induces CHI3L1 expression, but chitosan is relatively inert. This effect and inhibition of pro-inflammatory cytokine (IL-6) suggest that chitosan MPs may possess more potential for therapeutic uses in human airway allergic inflammation.


Asunto(s)
Quitina/farmacología , Quitosano/farmacología , Citocinas/biosíntesis , Células Epiteliales/efectos de los fármacos , Expresión Génica/efectos de los fármacos , Células A549 , Asma/patología , Quitina/administración & dosificación , Proteína 1 Similar a Quitinasa-3/biosíntesis , Proteína 1 Similar a Quitinasa-3/genética , Quitinasas , Quitosano/administración & dosificación , Citocinas/efectos de los fármacos , Sistemas de Liberación de Medicamentos , Células Epiteliales/metabolismo , Células Epiteliales/patología , Humanos , Inflamación/tratamiento farmacológico , Inflamación/metabolismo , Interleucina-6/biosíntesis , Interleucina-6/genética , Sistema Respiratorio/patología
8.
Parasitol Int ; 65(2): 99-104, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26518128

RESUMEN

Chitin and chitosan microparticles (MPs) are important immune system stimulators. The aim of this study was to evaluate the protective effects of these compounds in comparison with each other against Leishmania infection in BALB/c mice infected with Leishmania major (L. major). Female BALB/c mice were injected subcutaneously with 2×10(5) promastigotes. Chitin and/or chitosan MPs (<40 µm) were subcutaneously injected in the BALB/c mice with two-day intervals until two weeks. Mice in all groups were sacrificed at 12 weeks post-infection. Enumeration of viable parasites was performed using limiting dilution assay. Furthermore, the animals (5 mice/group) were sacrificed two weeks post-infection. The lymph node cells were isolated and the effects of the chitinous MPs on the proliferation and production of cytokines such as tumor necrosis factor alpha (TNF-α) and interleukin-10 (IL-10) were determined. The mean sizes of lesions were significantly smaller in chitin (0.6±0.12 mm) and chitosan treated groups (1.2±0.8 mm) than in the control group (6.2±1.7 mm) (P<0.05). The parasite load in the lymph nodes of the treated mice was significantly lower than that in the lymph nodes of controls (1.31×10(6) vs 8.24×10(7) parasite/lymph node [P=0.032] and 7.49×10(6) vs 8.24×10(7) parasite/lymph node [P=0.05] for chitin and chitosan MPs treatment, respectively). We found that chitinous MPs induced cell proliferation and that chitin but not chitosan increased TNF-α and IL-10 production. Chitin appears that it has more effect than chitosan against leishmaniasis. The current study revealed that chitinous MPs had significant activity against L. major and could be considered as new therapeutic modality in leishmaniasis.


Asunto(s)
Adyuvantes Inmunológicos , Quitina/inmunología , Quitosano/inmunología , Leishmania major , Leishmaniasis Cutánea/inmunología , Leishmaniasis Cutánea/terapia , Animales , Proliferación Celular , Quitina/administración & dosificación , Quitosano/administración & dosificación , Citocinas/biosíntesis , Citocinas/inmunología , Femenino , Inmunoterapia , Interferón gamma/biosíntesis , Leishmania major/inmunología , Leishmania major/fisiología , Leishmaniasis Cutánea/parasitología , Leishmaniasis Cutánea/prevención & control , Ganglios Linfáticos/citología , Ganglios Linfáticos/inmunología , Ratones Endogámicos BALB C , Carga de Parásitos , Absorción Subcutánea , Factor de Necrosis Tumoral alfa/biosíntesis
9.
Int J Mol Sci ; 16(9): 21931-49, 2015 Sep 10.
Artículo en Inglés | MEDLINE | ID: mdl-26378523

RESUMEN

The aim of this study was to examine the effects of oral administration of chitin nanofibers (CNFs) and surface-deacetylated (SDA) CNFs on plasma metabolites using metabolome analysis. Furthermore, we determined the changes in gut microbiota and fecal organic acid concentrations following oral administrations of CNFs and SDACNFs. Healthy female mice (six-week-old) were fed a normal diet and administered tap water with 0.1% (v/v) CNFs or SDACNFs for 28 days. Oral administration of CNFs increased plasma levels of adenosine triphosphate (ATP), adenosine diphosphate (ADP), and serotonin (5-hydroxytryptamine, 5-HT). Oral administration of SDACNFs affected the metabolisms of acyl-carnitines and fatty acids. The fecal organic level analysis indicated that oral administration of CNFs stimulated and activated the functions of microbiota. These results indicate that oral administration of CNFs increases plasma levels of ATP and 5-HT via activation of gut microbiota.


Asunto(s)
Quitina/administración & dosificación , Microbioma Gastrointestinal , Metaboloma , Nanofibras/administración & dosificación , Administración Oral , Animales , Análisis por Conglomerados , Metabolismo Energético , Heces/química , Femenino , Redes y Vías Metabólicas , Metabolómica/métodos , Ratones
10.
J Anim Sci ; 93(3): 1089-97, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26020885

RESUMEN

This study was conducted to determine the effect of dietary supplementation of a low dose of chito-oligosaccharide (COS) on intestinal morphology, immune response, antioxidant capacity, and barrier function in weaned piglets. A total of 120 weaned pigs (21 d of age; 7.86 ± 0.22 kg average BW) were randomly assigned (6 pens/diet; 10 pigs/pen) to 2 dietary treatments consisting of a basal diet (negative control) or the basal diet supplemented with COS (30 mg/kg) for a 14-d period. Six randomly selected piglets from each treatment were killed for blood and tissue sampling. No significant differences were observed in ADG, ADFI, and G:F between treatment and the control group. Piglets fed the COS-supplemented diet had greater ( < 0.05) stomach pH than those fed the control diet on d 14 postweaning. Dietary supplementation with COS reduced villus height ( < 0.05) and villus height:crypt depth ( < 0.05) in the ileum. Dietary COS supplementation tended to reduce villus height in the duodenum ( = 0.065) and jejunum ( = 0.058). There was no effect on crypt depth in the intestinal segments of treatment group. Piglets fed the COS-supplemented diet increased ( < 0.05) the number of intraepithelial lymphocytes in duodenum or jejunum and goblet cells of ileum. However, COS decreased ( < 0.05) the number of intraepithelial lymphocytes in ileum of weaned piglets. The concentrations of IL-10 (duodenum, jejunum, and ileum) and secretory immunoglobulin (SIgA; duodenum and ileum) were higher in piglets fed the COS-supplemented diet compared with control ( < 0.05). Dietary COS supplementation reduced ( < 0.05) the concentration of total antioxidant capacity and superoxide dismutase of the jejunum or ileum. The mRNA expression of occludin in the ileum and ZO-1 in jejunum and ileum had a significant change in piglets fed the COS-supplemented diet compared with the control group ( < 0.05). In conclusion, these results indicated that dietary COS supplementation at 30 mg/kg had no effects on promoting growth performance and tended to reduce villus height in the duodenum or jejunum of weaned piglets. The results further showed that supplemental COS at this level may cause an immune and oxidative stress response in small intestine and have compromised the intestinal barrier integrity in weaned piglets. The research will provide guidance on the low dosage of COS supplementation on weaning pigs.


Asunto(s)
Inmunidad Adaptativa/efectos de los fármacos , Antioxidantes/metabolismo , Quitina/análogos & derivados , Absorción Intestinal/efectos de los fármacos , Intestino Delgado/efectos de los fármacos , Porcinos/fisiología , Inmunidad Adaptativa/fisiología , Alimentación Animal/análisis , Animales , Quitina/administración & dosificación , Quitina/farmacología , Quitosano , Citocinas/metabolismo , Dieta/veterinaria , Suplementos Dietéticos , Relación Dosis-Respuesta a Droga , Femenino , Glutatión/metabolismo , Concentración de Iones de Hidrógeno , Interleucina-10/sangre , Absorción Intestinal/fisiología , Mucosa Intestinal/anatomía & histología , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/metabolismo , Intestino Delgado/anatomía & histología , Intestino Delgado/metabolismo , Masculino , Oligosacáridos , Porcinos/crecimiento & desarrollo , Porcinos/inmunología , Destete
11.
Int Forum Allergy Rhinol ; 5(8): 716-23, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25851155

RESUMEN

BACKGROUND: We investigated the effect of chitin on the inflammation and immune modulation of the nasal mucosa. This compound was compared to placebo and as a positive control we used lipopolysaccharide (LPS). METHODS: Fourteen healthy nonsmoking volunteers 22 to 28 years of age were included. All persons underwent exposure to chitin microparticles (CP) and placebo in a randomized double-blinded fashion. In a last session we used LPS from Enterobacter agglomerans in a single-blinded fashion. There were 2 weeks between each session. The outcome measures were Total Nasal Symptom Score (TNSS) and nasal lavage for cytokines and cells at 0, 3, 4, 8 hours. RESULTS: We showed that CP was only weakly inflammatory compared to LPS. In contrast to the LPS response, we did however show an immune-regulatory effect of CP on enhanced interleukin (IL)-4 and IL-6 responses known to downregulate T helper 2 (Th2) responses, indicating a potential beneficial effect of CP for the regulation of the allergic Th2 immune response. CONCLUSION: This study also shows that CP is well tolerated in healthy volunteers, and that does not induce significantly more symptoms compared to placebo. In fact there is a tendency for CP instillation to induce less rhinorrhoea compared to placebo.


Asunto(s)
Quitina/farmacología , Lipopolisacáridos/farmacología , Mucosa Nasal/metabolismo , Rinitis/metabolismo , Administración Intranasal , Adulto , Biomarcadores/metabolismo , Recuento de Células , Quitina/administración & dosificación , Estudios Cruzados , Citocinas/metabolismo , Método Doble Ciego , Regulación hacia Abajo , Femenino , Voluntarios Sanos , Humanos , Inmunidad Humoral/fisiología , Interleucina-4/metabolismo , Interleucina-6/metabolismo , Lipopolisacáridos/administración & dosificación , Masculino , Mucosa Nasal/inmunología , Obstrucción Nasal/inducido químicamente , Prurito/inducido químicamente , Rinitis/inmunología , Método Simple Ciego , Estornudo/efectos de los fármacos , Células Th2/inmunología , Adulto Joven
12.
Int J Pharm ; 479(2): 312-9, 2015 Feb 20.
Artículo en Inglés | MEDLINE | ID: mdl-25550211

RESUMEN

Ultrapure oligochitosans have been recently reported as efficient non-viral vectors for the delivery of pCMS-EGFP plasmid (5.5kbp) to the cornea and retina. However, the delivery of oncolytic adenoviral plasmids (40kbp) represents a unique challenge. In this work, we elaborated self assembled O15 and O25 UOC/pAdTLRGD polyplexes, and we studied the influence of the N/P ratio, the pH of the transfection medium and the salt concentration on the particle size and zeta potential by an orthogonal experimental design. All polyplexes showed a particle size lower than 200nm and a positive zeta potential. These parameters were influenced by the N/P ratio, salt concentration, and pH of the transfection medium. The selected polyplexes were able to bind, release, and protect the plasmid from DNase degradation. Transfection experiments in HEK293 and A549 cell lines demonstrated that UOC/pAdTLRGD polyplexes were able to deliver the plasmid and transfect both cell lines. These results suggest that O15 and O25 UOC based polyplexes are suitable for future in vivo applications.


Asunto(s)
Adenoviridae/genética , Quitina/análogos & derivados , ADN/administración & dosificación , Polímeros/administración & dosificación , Línea Celular Tumoral , Quitina/administración & dosificación , Quitosano , Vectores Genéticos , Células HEK293 , Humanos , Concentración de Iones de Hidrógeno , Oligosacáridos , Tamaño de la Partícula , Plásmidos , Transfección/métodos
13.
Carbohydr Polym ; 115: 448-56, 2015 Jan 22.
Artículo en Inglés | MEDLINE | ID: mdl-25439918

RESUMEN

Anti-inflammatory effects of oral administration of the glucosamine oligomers (chito-oligosaccharides: COS) were evaluated in an experimental model of inflammatory bowel disease (IBD). Oral administration of COS improved shortening of colon length and tissue injury (as assessed by histology) in mice. Oral administration of COS inhibited inflammation in the colonic mucosa by suppression of myeloperoxidase activation in inflammatory cells, as well as activation of nuclear factor-kappa B, cyclooxygenase-2, and inducible nitric oxide synthase. Oral administration of COS also reduced serum levels of pro-inflammatory cytokines (tumor necrosis factor-α and interleukin-6). Moreover, it prolonged survival time in mice. These data suggest that COS have anti-inflammatory effects in an experimental model of IBD, and could be new functional foods for IBD patients.


Asunto(s)
Antiinflamatorios/administración & dosificación , Antiinflamatorios/farmacología , Quitina/análogos & derivados , Enfermedades Inflamatorias del Intestino/tratamiento farmacológico , Administración Oral , Animales , Antiinflamatorios/uso terapéutico , Peso Corporal/efectos de los fármacos , Quitina/administración & dosificación , Quitina/farmacología , Quitina/uso terapéutico , Quitosano , Colon/efectos de los fármacos , Colon/patología , Citocinas/sangre , Modelos Animales de Enfermedad , Femenino , Enfermedades Inflamatorias del Intestino/sangre , Enfermedades Inflamatorias del Intestino/metabolismo , Enfermedades Inflamatorias del Intestino/patología , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/metabolismo , Mucosa Intestinal/patología , Ratones , Ratones Endogámicos C57BL , FN-kappa B/metabolismo , Oligosacáridos , Tamaño de los Órganos/efectos de los fármacos , Análisis de Supervivencia
14.
Drug Deliv ; 22(1): 100-10, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24471693

RESUMEN

CONTEXT: Ultrapure oligochitosans (UOCs) have recently been reported as efficient nonviral vectors for corneal and retinal gene delivery. However, the influence of some physicochemical factors on the transfection efficiency, such as the pH, remains unclear. Deeper in vitro research of these factors could provide valuable information for future clinical applications. OBJECTIVE: The aim of this study is to determine the influence of the pH decrease on the transfection efficiency of UOC/pDNA polyplexes in HEK293 and ARPE19 cells. MATERIALS AND METHODS: We elaborated self-assembled UOC/pCMS-EGFP polyplexes. The influence of the most important factors on the particle size and the zeta potential was studied by an orthogonal experimental design. We evaluated, in vitro, the cellular uptake and the transfection efficiency by flow cytometry, and the cytotoxicity of the vectors by CCK-8 assay. RESULTS AND DISCUSSION: The pH of the medium strongly influences the physicochemical properties of the polyplexes, and by its modulation we are able to control their superficial charge. A significant increase on the cellular uptake and transfection efficiency of UOCs was obtained when the pH was acidified. Neither of our UOC/pCMS-EGFP polyplexes caused cytotoxicity; however, cells treated with Lipofectamine 2000™ showed decreased cell viability. CONCLUSION: This kind of UOC vectors could be useful to transfect cells that are in an acidic environment, such as tumor cells. However, additional in vivo studies may be required in order to obtain an effective and safe medicine for nonviral gene therapy purpose.


Asunto(s)
Quitina/análogos & derivados , ADN/administración & dosificación , Terapia Genética/métodos , Transfección/métodos , Línea Celular , Supervivencia Celular , Quitina/administración & dosificación , Quitosano , Citometría de Flujo , Técnicas de Transferencia de Gen , Vectores Genéticos , Proteínas Fluorescentes Verdes/genética , Células HEK293 , Humanos , Concentración de Iones de Hidrógeno , Lípidos/farmacología , Oligosacáridos , Tamaño de la Partícula , Plásmidos , Epitelio Pigmentado de la Retina/citología
15.
Int J Pharm ; 473(1-2): 579-90, 2014 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-25063077

RESUMEN

The RNA interference (RNAi) constitutes a conservative mechanism in eukaryotic cells that induces silencing of target genes. In mammalians, the RNAi is triggered by siRNA (small interfering RNA) molecules. Due to its potential in silencing specific genes, the siRNA has been considered a potential alternative for the treatment of genetic and acquired diseases. However, the siRNA therapy has been limited by its low stability and rapid degradation in presence of nucleases, low cellular uptake, and immune response activation. In order to overcome these drawbacks, we propose the synthesis and characterization of non-viral delivery systems using chitosan derivatives to obtain siRNA complexes (polyplexes). The non-viral delivery systems synthesized included PEG-g-OCs (oligochitosan) and PEG-g-Cs (chitosan medium molecular weight). Both systems allowed the formation of siRNA polyplexes, increased the stability of siRNA in the presence of nucleases, enhanced cellular internalization, and showed low toxicity in the A549 cell line. Finally, the complexes obtained with the PEG-g-OCs system showed silencing activity in a GFP model in the cell line A549 in comparison with naked siRNA.


Asunto(s)
Quitina/análogos & derivados , Quitosano/administración & dosificación , Nanoestructuras/administración & dosificación , ARN Interferente Pequeño/administración & dosificación , Transporte Biológico , Línea Celular Tumoral , Quitina/administración & dosificación , Quitina/química , Quitosano/química , Proteínas Fluorescentes Verdes/genética , Humanos , Nanoestructuras/química , Oligosacáridos , Interferencia de ARN , ARN Interferente Pequeño/química
16.
Dev Comp Immunol ; 47(1): 17-24, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24968077

RESUMEN

The immunostimulating effects of oligochitosan have been proven in several fish, however, the mechanisms underlying the stimulation are not characterized. In the present study, the effects of oligochitosan were investigated using macrophages isolated from blunt snout bream (Megalobrama amblycephala). The results showed that the phagocytic activity of the macrophages was enhanced by the addition of oligochitosan in vitro and in vivo. The two of the most important antimicrobial pathways of macrophages, NADPH oxidase and iNOS pathways were included for further studies. The amounts of superoxide anion and the mRNAs of the five subunits of NADPH oxidase genes were significantly enhanced in the oligochitosan-treated macrophages and macrophages isolated from fish fed with feed containing oligochitosan. In addition, the NO production, iNOS activity and iNOS gene expression were all significantly increased in the presence of oligochitosan. Furthermore, the mRNA levels of the TNF-α and IL-1ß were also significantly increased in the macrophages derived from fish fed with oligochitosan. In conclusion, the stimulation effects of oligochitosan on the phagocytic activity of the fish macrophages were associated with respiratory burst coupled with nitric oxide production.


Asunto(s)
Quitina/análogos & derivados , Cyprinidae/inmunología , Macrófagos/inmunología , Óxido Nítrico/metabolismo , Fagocitosis , Estallido Respiratorio , Animales , Quitina/administración & dosificación , Quitosano , Cyprinidae/metabolismo , Macrófagos/metabolismo , NADPH Oxidasas/metabolismo , Óxido Nítrico Sintasa de Tipo II/metabolismo , Oligosacáridos
17.
Int J Biol Macromol ; 67: 279-88, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24685461

RESUMEN

Cyto-compatible, 80nm sized chitin/PLGA composite nanogels (chit/PLGA-comp NGs) were prepared by regeneration method and characterized. The multifaceted chit/PLGA-comp NGs were surface modified with Au, Fe3O4, CdTe/ZnTe-QDs and umbelliferone, respectively. 185nm sized Au-chit/PLGA-comp NGs, 170nm sized QD-chit/PLGA-comp-NGs and 160nm sized Fe3O4-chit/PLGA-comp-NGs showed RF heating. The QD-chit/PLGA-comp-NGs and 180nm sized umb-chit/PLGA-comp-NGs were well uptaken by Escherichia coli, Staphylococcus aureus and Candida albicans. The chit/PLGA-comp NGs could be useful for microbial monitoring and RF application for cancer therapy. The preliminary data showed that multifaceted chit/PLGA-comp-NGs could be useful for hyperthermia for cancer treatment and microbial labelling and imaging.


Asunto(s)
Quitina/química , Ácido Láctico/química , Polietilenglicoles/química , Polietileneimina/química , Ácido Poliglicólico/química , Candida albicans/efectos de los fármacos , Candida albicans/aislamiento & purificación , Quitina/administración & dosificación , Quitina/síntesis química , Escherichia coli/efectos de los fármacos , Escherichia coli/aislamiento & purificación , Humanos , Ácido Láctico/administración & dosificación , Ácido Láctico/síntesis química , Nanocompuestos/administración & dosificación , Nanocompuestos/química , Nanogeles , Neoplasias/tratamiento farmacológico , Neoplasias/patología , Tamaño de la Partícula , Polietilenglicoles/administración & dosificación , Polietilenglicoles/síntesis química , Polietileneimina/administración & dosificación , Polietileneimina/síntesis química , Ácido Poliglicólico/administración & dosificación , Ácido Poliglicólico/síntesis química , Copolímero de Ácido Poliláctico-Ácido Poliglicólico , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/aislamiento & purificación
18.
Immunity ; 40(3): 414-24, 2014 Mar 20.
Artículo en Inglés | MEDLINE | ID: mdl-24631157

RESUMEN

Chitin, a polysaccharide constituent of many allergens and parasites, initiates innate type 2 lung inflammation through incompletely defined pathways. We show that inhaled chitin induced expression of three epithelial cytokines, interleukin-25 (IL-25), IL-33, and thymic stromal lymphopoietin (TSLP), which nonredundantly activated resident innate lymphoid type 2 cells (ILC2s) to express IL-5 and IL-13 necessary for accumulation of eosinophils and alternatively activated macrophages (AAMs). In the absence of all three epithelial cytokines, ILC2s normally populated the lung but failed to increase IL-5 and IL-13. Although eosinophils and AAMs were attenuated, neutrophil influx remained normal without these epithelial cytokines. Genetic ablation of ILC2s, however, enhanced IL-1ß, TNFα, and IL-23 expression, increased activation of IL-17A-producing γδ T cells, and prolonged neutrophil influx. Thus, chitin elicited patterns of innate cytokines that targeted distinct populations of resident lymphoid cells, revealing divergent but interacting pathways underlying the tissue accumulation of specific types of inflammatory myeloid cells.


Asunto(s)
Quitina/inmunología , Inmunidad Innata , Inflamación/inmunología , Inflamación/metabolismo , Activación de Linfocitos/inmunología , Receptores de Antígenos de Linfocitos T gamma-delta/metabolismo , Subgrupos de Linfocitos T/inmunología , Subgrupos de Linfocitos T/metabolismo , Animales , Quitina/administración & dosificación , Citocinas/biosíntesis , Citocinas/genética , Eosinófilos/inmunología , Eosinófilos/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Inflamación/genética , Pulmón/inmunología , Pulmón/metabolismo , Activación de Macrófagos/inmunología , Macrófagos/inmunología , Macrófagos/metabolismo , Ratones , Ratones Noqueados
19.
Eur J Pharm Biopharm ; 83(2): 131-40, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23059418

RESUMEN

Ultrapure oligochitosans have recently been evaluated as a promising tool for corneal gene therapy; however, there are no reports regarding the potential use of this polymer in other ocular tissues. We have prepared and characterized at pH 7.1 oligochitosan/pCMS-EGFP polyplexes to evaluate the transfection efficiency in rat retinas after subretinal and intravitreal administration. Polyplexes were characterized in terms of shape, size, surface charge, DNA condensation, and transfection efficiency in HEK-293 and ARPE-19 culture cells. Polyplexes were positively charged, around 10 mV, and size oscillated between 256.5 ± 56 and 67.3 ± 0.44 nm, depending on the nitrogenous/phosphate ratio. Polyplexes efficiently protected the plasmid against enzymatic digestion. A drastic increase in transfection efficiency was observed when pH slightly decreased from 7.4 to 7.1 in both HEK-293 (from 19.1% to 51.5%) and ARPE-19 (from 2.0% to 36.5%) cells (data normalized to Lipofectamine™ 2000). In rat retinas, subretinal administrations transfected cells mainly in the RPE layer, whereas intravitreal injections transfected cells in the inner nuclear and plexiform layers of the retina and mainly in the ganglion cell layer. This study establishes the base for future treatments of genetic retinal disorders with low molecular weight oligochitosan polyplexes.


Asunto(s)
Quitina/análogos & derivados , ADN/administración & dosificación , Retina/metabolismo , Animales , Línea Celular , Quitina/administración & dosificación , Quitosano , Técnicas de Transferencia de Gen , Terapia Genética/métodos , Células HEK293 , Humanos , Masculino , Peso Molecular , Oligosacáridos , Tamaño de la Partícula , Polímeros/metabolismo , Ratas , Ratas Sprague-Dawley , Transfección/métodos
20.
Eur J Pharm Sci ; 48(1-2): 323-31, 2013 Jan 23.
Artículo en Inglés | MEDLINE | ID: mdl-23201002

RESUMEN

Non-viral gene therapy represents a promising approach for the treatment of retinal diseases. However, the lack of an efficient carrier hampers the implementation of this therapy. In this study, we evaluated low molecular weight ultrapure oligochitosans for the delivery of the pCMS-EGFP plasmid into the rat retina cells after subretinal and intravitreal administrations. Polyplexes were technologically characterized. Resulting polyplexes based on ultrapure oligochitosans were slightly spherical, protected the plasmid against enzymatic digestion, and their charge and size values ranged from 8 to 14 millivolts and from 150 to 69 nm respectively depending on the N/P ratio. In HEK-293 cultured cells, transfection efficiency significantly increased from 12% to 30% when pH decreased from 7.4 to 7.1 (data normalized to Lipofectamine™ 2000). However, no significant transfection was detected in ARPE-19 cultured cells. Subretinal administrations transfected mainly the pigmented cells of the retinal pigment epithelium and the light sensitive photoreceptor cells, whereas intravitreal injections transfected cells in the ganglion cell layer, blood vessels in the inner layers of the retina and photoreceptors. These results support the potential use of oligochitosans for delivering genetic material into retinal cells in vivo.


Asunto(s)
Quitina/análogos & derivados , ADN/administración & dosificación , Proteínas Fluorescentes Verdes/genética , Retina/metabolismo , Animales , Línea Celular , Quitina/administración & dosificación , Quitina/química , Quitosano , ADN/química , Terapia Genética/métodos , Vectores Genéticos , Proteínas Fluorescentes Verdes/química , Células HEK293 , Humanos , Masculino , Oligosacáridos , Plásmidos , Ratas , Ratas Sprague-Dawley
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA